26.74
price down icon2.59%   -0.71
after-market Dopo l'orario di chiusura: 26.52 -0.22 -0.82%
loading
Precedente Chiudi:
$27.45
Aprire:
$27.45
Volume 24 ore:
1.88M
Relative Volume:
0.42
Capitalizzazione di mercato:
$19.86B
Reddito:
$956.00K
Utile/perdita netta:
$-221.32M
Rapporto P/E:
-83.56
EPS:
-0.32
Flusso di cassa netto:
$-142.25M
1 W Prestazione:
+0.75%
1M Prestazione:
+29.81%
6M Prestazione:
+23.57%
1 anno Prestazione:
+148.05%
Intervallo 1D:
Value
$26.50
$27.73
Intervallo di 1 settimana:
Value
$26.50
$29.07
Portata 52W:
Value
$8.88
$36.91

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
Nome
Summit Therapeutics Inc
Name
Telefono
305-203-2034
Name
Indirizzo
601 BRICKELL KEY DRIVE, MIAMI
Name
Dipendente
159
Name
Cinguettio
@summitplc
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
SMMT's Discussions on Twitter

Confronta SMMT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SMMT
Summit Therapeutics Inc
26.74 20.39B 956.00K -221.32M -142.25M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-01 Iniziato UBS Buy
2025-06-11 Iniziato Leerink Partners Underperform
2025-03-26 Aggiornamento Citigroup Neutral → Buy
2025-03-21 Iniziato Cantor Fitzgerald Overweight
2025-03-12 Iniziato Evercore ISI Outperform
2025-02-28 Iniziato Goldman Buy
2025-01-08 Iniziato Truist Buy
2024-12-11 Iniziato Wells Fargo Overweight
2024-12-06 Iniziato Jefferies Buy
2024-11-04 Iniziato JMP Securities Mkt Outperform
2024-09-27 Downgrade Citigroup Buy → Neutral
2024-08-12 Iniziato H.C. Wainwright Buy
2024-05-07 Iniziato Citigroup Buy
2024-03-26 Iniziato Stifel Buy
2018-06-28 Downgrade Janney Buy → Neutral
2018-05-02 Iniziato Janney Buy
2018-04-12 Reiterato Needham Buy
2018-02-13 Iniziato BTIG Research Buy
2018-01-04 Iniziato SunTrust Buy
2017-12-01 Ripresa H.C. Wainwright Buy
2016-11-16 Reiterato RBC Capital Mkts Outperform
2016-10-05 Reiterato Needham Buy
2016-09-16 Iniziato H.C. Wainwright Buy
2015-03-30 Iniziato Needham Buy
2015-03-30 Iniziato Oppenheimer Outperform
Mostra tutto

Summit Therapeutics Inc Borsa (SMMT) Ultime notizie

pulisher
07:16 AM

Is Summit Therapeutics Inc. Stock a Good Fit for Conservative InvestorsSmart Trade Mapping with Entry Details - Newser

07:16 AM
pulisher
05:11 AM

Is Summit Therapeutics Inc. stock a growth or value playFree Day Trading Signals With High Precision - Newser

05:11 AM
pulisher
04:18 AM

How high can Summit Therapeutics Inc. stock goFree Weekly Setup With 3x Return Potential - Newser

04:18 AM
pulisher
Jul 28, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Summit Therapeutics Inc. (SMMT) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

Summit Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 28, 2025
pulisher
Jul 28, 2025

Is Summit Therapeutics Inc. stock poised for growthTechnical Setup Guide for Daily Watchlist - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Summit Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 - Investor's Business Daily

Jul 28, 2025
pulisher
Jul 28, 2025

Ivonescimab's Dual-Action Revolution: A Catalyst for Akeso and Summit Therapeutics in the $500M+ Lung Cancer Market - AInvest

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Summit Therapeutics Inc. stock attracting strong analyst attentionUnmatched profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc.SMMT - MarketScreener

Jul 27, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc.SMMT - PR Newswire

Jul 27, 2025
pulisher
Jul 27, 2025

Is Summit Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisVolume Spike Monitors - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

When is Summit Therapeutics Inc. stock expected to show significant growthAchieve consistent profits with proven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Summit Therapeutics Jumps 4% As Technicals Signal Bullish Breakout Potential - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Summit Therapeutics Inc. (SMMT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Summit Therapeutics Soars 4.64%—Could This Biotech Breakthrough Signal a Game-Changer? - AInvest

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Summit Therapeutics Inc. stock priceConsistent double returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Summit Therapeutics Inc. (SMMT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

Bank of New York Mellon Corp Has $6.57 Million Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT) - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Will Summit Therapeutics Inc. stock benefit from AI tech trendsTriple-digit growth rates - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 24, 2025
pulisher
Jul 23, 2025

Is Summit Therapeutics Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

Meet the Biotech Stock That Rocketed 775% Higher - AOL.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Summit Therapeutics Inc. stockExplosive capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Summit Therapeutics Inc. (SMMT) And Encourages Investors to Connect - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results - The Motley Fool

Jul 22, 2025
pulisher
Jul 22, 2025

Summit Therapeutics Inc. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Summit Therapeutics Inc. (SMMT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

3 Monster Stocks in the Making to Buy Right Now - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

Trading (SMMT) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 20, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Shares Acquired by Cerity Partners LLC - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 02:49:19 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Summit Therapeutics Inc. (SMMT) And Encourages Investors to Reach Out - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 18, 2025

Principal Financial Group Inc. Has $4.75 Million Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT) - Defense World

Jul 18, 2025

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$105.00
price up icon 3.19%
$37.27
price up icon 0.57%
$77.38
price up icon 10.28%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Capitalizzazione:     |  Volume (24 ore):